If you missed our live Orphan Drug Designation (ODD) webinar you can view on demand now.

Achieving ODD status, is a significant step enabling your product to be licensed faster, cost-efficiently, and achieve market exclusivity for 10 years.

Join this 1-hour webinar where the audience will gain a practical overview in the steps to achieve ODD status including:

  • Review of the ODD eligibility criteria; including a registered medicine with a new ‘orphan indication’
  • An overview of ODD incentives; tax, marketing approval, market exclusivity
  • Practical application, process and insights
  • EU & FDA requirements, assessing the differences